期刊文献+

携带肿瘤坏死因子相关细胞凋亡诱导配体重组腺相关病毒的构建及鉴定 被引量:3

Construction and identification of recombined adeno-associated virus with tumor necrosis factor related apoptosis inducing ligand
下载PDF
导出
摘要 目的:构建一种携带肿瘤坏死因子相关细胞凋亡诱导配体(tumor necrosis factor related apoptosis inducing ligand,TRAIL)基因的重组腺相关病毒(recombined adeo-associated virus,rAAV)载体。方法:实验于2005-09/2006-04在中山大学附属第一医院普通外科实验室完成。首先构建携带可溶性肿瘤坏死因子相关细胞凋亡诱导配体基因的穿梭质粒pAAV-sTRAIL,利用磷酸钙共沉淀法将穿梭质粒共转染入HEK293细胞中,采用细胞内质粒DNA同源重组法构建重组腺相关病毒rAAV-sTRAIL。以噬斑分析法筛选单克隆重组腺相关病毒;聚合酶链反应法鉴定阳性重组腺相关病毒;氯化铯密度梯度离心法纯化病毒;紫外分光光度仪测定病毒颗粒数及纯度,噬斑分析法测定病毒感染滴度;Western blot检测rAAV-sTRAIL在293细胞中的表达情况。结果:成功构建了重组腺相关病毒载体rAAV-sTRAIL,制备的病毒纯度好、滴度高,且在293转导细胞中能有效表达目的基因sTRAIL。结论:构建的重组腺相关病毒载体rAAV-sTRAIL,为组织工程相关细胞转基因构建及临床应用提供先进的载体系统。 AIM: To construct a kind of recombined adeno-associated virus (rAAV) encoding soluble tumor necrosis factor related apoptosis inducing ligand (sTRAIL) gene cDNA. METHODS: The shuttle plesmid pAAV-sTRAIL was first constructed with sTRAIL, end then transfected into HEK 293 cells by calcium phospheteprecipitation method. Recombinant edeno-essociated virus rAAV-sTRAIL was constructed by homologous recombination in 293 calls. Monoclonel rAAV-sTRAIL was screened by plaque assay; positive virus was identified by PCR; purified virus were prepared by CsCl density gradient centrifugation; virus particle number and purity were determined by recording spectrophotometer measurements end functional titers in plaque-forming units were determined by end-point dilution infection on 293 cells. Western blot was employed to detect the expression of rAAV-sTRAIL in 293 calls. RESULTS: rAAV-sTRAIL was constructed successfully and verified with high particles titers and good purification. The western blot showed that rAAV-s TRAIL expressed sTRAIL proteins in 293 calls. CONCLUSION: rAAV-sTRAIL provides an advanced gene expression vector tool for the study of the related transgenic construction in tissue engineering end the clinical application of TRAIL.
出处 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2007年第10期1966-1968,1971,共4页 Journal of Clinical Rehabilitative Tissue Engineering Research
基金 广东省科技计划项目资助(53056) 广州市医药卫生科技项目资助(2005-YB-023) 广东省医学科研基金项目资助(A2004534 A2006517)~~
  • 相关文献

参考文献11

  • 1Wiley SR,Schooley K,Smolak P J,et al.Identification and characterization of a new member of the TNF family that induces apoptosis.lmmunity 1995;3(6):673-682
  • 2Boehrer S,Nowak D,Hoelzer D,et al.The molecular biology of TRAIL-mediated signaling and its potential therapeutic exploitation in hematopoietic malignancies.Curr Med Chem 2006;13(18):2091-2100
  • 3Bremer E,Samplonius DF,van Genne L,et al.Simultaneous inhibition of epidermal growth factor receptor (EGFR) signaling and enhanced activation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor-mediated apoptosis induction by an scFv:sTRAIL fusion protein with specificity for human EGFR.J Biol Chem 2005;280(11):10025-10033
  • 4Buchsbaum DJ,Zhou T,Lobuglio AF.TRAIL receptor-targeted therapy.Future Oncol 2006;2(4):493-508
  • 5Liu YX,Zhu X,Ma ZY,et al.Expression,purification of biological activity of rsTRAIL in E.coli.Clin Sci Bulletin 1999;44(14):1306-1309
  • 6Yoo J,Choi S,Hwang KS,et al.Adeno-associated virus-mediated gene transfer of a secreted form of TRAIL inhibits tumor growth and occurrence in an experimental tumor model.J Gene Med 2006;8(2):163-174
  • 7Lee J,Hampl M,Albert P,et al.Antitumor activity and prolonged expression from a TRAIL-expressing adenoviral vector.Neoplasia 2002;4(4):312-323
  • 8Wu SH,Dong L,Chen ZQ.Akt1/p27pip1 pathway mediates inhibition of LXA4 on TNFα-induced proliferation of rat mesangial cells.J Nanjing Med Univ 2004;18(6):283-287
  • 9Shi J,Zheng D,Liu Y,et al.Overexpression of soluble TRAIL induces apoptosis in human lung adenocarcinoma and inhibits growth of tumorxenografts in nude mice.Cancer Res 2005;65(5):1687-1692
  • 10Kato S,Shirato K,Imaizumi K,et al.Anticancer effects of phenoxazine derivatives combined with tumor necrosis factor-related apoptosis-inducing ligand on pancreatic cancer cell lines,KLM-1 and MIA-PaCa-2.Oncol Rep 2006;15(4):843-848

同被引文献21

  • 1Ashkenazi A, Pal RC, Fong S, et al. Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Invest, 1999, 104(2) :155- 162.
  • 2Walczak H, Miller RE, Ariail K, et al. Tumoricidal activity of tumor necrosis factor-related apoptosis inducing ligand in vivo. Nat Med, 1999, 5(2) :157-163.
  • 3Herr I, Schemmer P, Buchler MW. On the TRAIL to therapeutic intervention in liver disease. Hepatology, 2007, 46( 1 ) : 266-274.
  • 4Shohet RV, Chen S, Zhou YT, et al. Echocardiographic destruction of albumin microbubbles directs gene delivery to the myocardium. Circulation, 2000, 101 (22) :2554-2556.
  • 5Mukherjee D, Wong J, Giffin B, et al. Ten fold auguention of endothelial uptake of vascular endothelial growth factor with ultrasound after systemic administration. J Am Coil Cardiol, 2000, 35 (6):1678- 1686.
  • 6Duvshani-Eshet M, Machluf M. Therapeutic ultrasound optimization for gene delivery:a key factor achieving nuclear DNA localization. J Control Release, 2005, 108(2-3) :513-528.
  • 7Wiley SR, Schooley K, Smolak PJ, et al. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity, 1995,3:673-682.
  • 8Ashkenazi A, Pai RC, Fong S, et al. Safety and anti-tumor activity of recombinant soluble Apo2 ligand. J Clin Invest, 1999, 104:155-162.
  • 9Walczak H, Miller RE, Ariail K, et al. Tumoricidal activity of tumor necrosis factor-related apoptosis inducing ligand in vivo. Nat Med, 1999,5:157-163.
  • 10Shohet RV, Chen S, Zhou YT, et al. Echocardiographic destruction of albumin microbubbles directs gene delivery to the myocardium. Circulation, 2000, 101:2554-2556.

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部